AVITA Medical (RCEL) Depreciation & Amortization (CF) (2019 - 2025)
AVITA Medical (RCEL) posted Depreciation & Amortization (CF) of $700000.0 for Q4 2025, up 21.95% on a QoQ basis from $574000.0 in Q3 2025, and up 71.15% year-over-year from $409000.0 in Q4 2024.
AVITA Medical (RCEL) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends
AVITA Medical's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $700000.0 for Q4 2025.
- Quarterly Depreciation & Amortization (CF) rose 71.15% year-over-year to $700000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.3 million (up 108.44% YoY) and the FY2025 annual result came in at $2.3 million, up 108.44% from the prior year.
- Depreciation & Amortization (CF) was $700000.0 for Q4 2025 at AVITA Medical, up from $574000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $700000.0 in Q4 2025 and bottomed at -$242000.0 in Q4 2022.
- A 5-year average of $287944.4 and a median of $203500.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) slumped 74.85% — and 2023, when it surged 177.27%.
- AVITA Medical's Depreciation & Amortization (CF) stood at $517000.0 in 2021, then slumped by 146.81% to -$242000.0 in 2022, then jumped by 177.27% to $187000.0 in 2023, then surged by 118.72% to $409000.0 in 2024, then soared by 71.15% to $700000.0 in 2025.
- Business Quant data shows RCEL's Depreciation & Amortization (CF) at $700000.0 in Q4 2025, $574000.0 in Q3 2025, and $552000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | 700,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 700,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | 574,000.00 |
| Sep 30, 2025 | 574,000.00 |
| Jun 30, 2025 | 552,000.00 |
| Jun 30, 2025 | 552,000.00 |
| Mar 31, 2025 | 521,000.00 |
| Mar 31, 2025 | 521,000.00 |
| Dec 31, 2024 | 409,000.00 |
| Dec 31, 2024 | 409,000.00 |
| Sep 30, 2024 | 310,000.00 |
| Sep 30, 2024 | 310,000.00 |
| Jun 30, 2024 | 204,000.00 |
| Jun 30, 2024 | 204,000.00 |
| Mar 31, 2024 | 203,000.00 |
| Mar 31, 2024 | 203,000.00 |
| Dec 31, 2023 | 187,000.00 |
| Dec 31, 2023 | 187,000.00 |
| Sep 30, 2023 | 164,000.00 |
| Sep 30, 2023 | 164,000.00 |